Tuesday, August 4, 2026

Job Offer or Trap? North Korea Poses as U.S. Companies in Crypto Hack

North Korean hackers created fake U.S. companies to target cryptocurrency developers with malware, leading to FBI intervention.

How Trump’s First Year Shapes Korea’s New Foreign Policy Strategy in 2026

Trump's second term emphasizes hardline policies, urging South Korea to adapt its strategies amid a shifting U.S. focus on domestic stability.

Samsung’s Onyx Screen Makes Movie Nights Way Brighter—and Sharper

Samsung unveils Onyx, a cinema LED screen with 4K resolution and HDR, enhancing the movie experience at CineEurope 2025.

Tag: Daewoong Pharmaceutical

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Daewoong Pharma Signs $1.45 Billion MENA Export Deal for ‘Enavogliflozin,’ Marking Record Global Sales

Daewoong Pharmaceutical's diabetes drug Enblo secures a $1.45 billion deal to enter MENA markets, marking a significant milestone.

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Daewoong Pharmaceutical Partners With Seers and TR to Develop Integrated Smart Ward Respiratory Care Solution

Daewoong Pharmaceutical signed an MOU with Cears and TR for the expansion of digital healthcare solutions.

Daewoong Pharmaceutical Gains Mexico Approval for Type 2 Diabetes Drug as Latin America Expansion Accelerates

Daewoong Pharmaceutical's type 2 diabetes drug Enblo has received approval in Mexico, a key market in Latin America.

Daewoong Pharmaceutical Completes Global Phase 2 Trials for First-in-Class IPF Treatment

Daewoong Pharmaceutical completes patient recruitment for a Phase 2 trial of Bersiporocin, a potential treatment for idiopathic pulmonary fibrosis.

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Daewoong Pharmaceutical and Puzzle AI to Supply AI Medical Record Solution CL Note

Daewoong Pharmaceutical partners with Puzzle AI to enhance digital healthcare with CL Note, streamlining hospital operations and patient care.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

Daewoong Pharmaceutical hosted the "Nabota Master Class" for 74 medical professionals from 13 countries, focusing on safety and clinical application.

Daewoong Pharmaceutical Expands Indication for Fexuclue: What This Means for 2026

Daewoong Pharmaceutical submits Phase 3 trial plan for Fexuclue to treat gastric ulcers, aiming to enhance treatment options and patient quality of life.

2026 Digital Healthcare Revolution: How Daewoong Pharmaceutical and Puzzle AI are Automating Medical Records

Daewoong Pharmaceutical's Innovare Partners Day showcased AI in healthcare, featuring voice-based EMR and innovations in brain health.

Daewoong’s Hub System Aims to End Drug Shortages With Predictive Data

Daewoong Pharmaceutical is enhancing drug distribution with a data-driven hub system for better inventory management and transparency.

Discover the Breakthrough: Daewoong’s CleanCol Tablet Reduces Dosage for Effective Colon Cleansing

Daewoong Pharmaceutical's Cleancol Tab. shows effective bowel cleansing with fewer tablets, improving patient adherence during colonoscopy prep.

CM Hospital’s thynC System: The Future of Patient Monitoring and Safety in Healthcare

Daewoong Pharmaceutical launches thynC, an AI-powered monitoring system at CM Hospital to enhance patient safety and healthcare quality.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.